L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
47,450
-1,750 (-3.56%)
Sep 11, 2026, 3:30 PM KST

L&C BIO Co.,LTD Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-149,411-138,175141,59648,3614,54413,814
Depreciation & Amortization
8,9958,2346,7545,6544,5082,902
Loss (Gain) From Sale of Assets
-492.15-92.81278.45-163.01-75.75-42.98
Asset Writedown & Restructuring Costs
72,52072,520-2,423--
Loss (Gain) From Sale of Investments
7,8121,081-140,830-62,1781,74076.02
Loss (Gain) on Equity Investments
794.2195.082,414437.29806.4-3,743
Stock-Based Compensation
1,223270.63149.56138.88375.84727.41
Provision & Write-off of Bad Debts
277.3683.92-722.58399.09-187.79-329.56
Other Operating Activities
87,71270,076-15,59419,2603,6154,692
Change in Accounts Receivable
-10,748-3,149-2,766-5,429-53.77-3,285
Change in Inventory
6,0743,475-1,437-12,151-23,269-4,554
Change in Accounts Payable
537.74-1,906183.95-1,1581,709754.1
Change in Other Net Operating Assets
812.63-48.41,406-7,728213.3-104.08
Operating Cash Flow
26,10612,565-8,567-12,133-6,07610,907
Operating Cash Flow Growth
3235.18%----47.01%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-29,981-15,810-4,715-24,503-37,531-10,251
Sale of Property, Plant & Equipment
0.152.56544.78256.73-120.91
Cash Acquisitions
-443.08-14,332-11,678--1,912-
Sale (Purchase) of Intangibles
-4,770-1,225-629.02-421.0813.05-1,137
Investment in Securities
7,852-3,13023,29549,856-43,867-6,240
Other Investing Activities
280.91237.37-28,422-288.46-265.74-1,911
Investing Cash Flow
-26,333-32,890-21,94624,634-83,633-20,488

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,77023,6008,38117,949-
Long-Term Debt Issued
-70,21619,690-71,5936,000
Total Debt Issued
13,93872,98643,2908,38189,5426,000
Short-Term Debt Repaid
--16,360--9,641-8,282-
Long-Term Debt Repaid
--32,004-8,451-1,676-1,271-663.01
Total Debt Repaid
-26,493-48,364-8,451-11,317-9,553-663.01
Net Debt Issued (Repaid)
-12,55424,62234,839-2,93679,9895,337
Issuance of Common Stock
8,45217,312----
Repurchase of Common Stock
-10,020-10,020--840--2,048
Dividends Paid
-1,218-1,122-2,268-1,115-1,115-1,078
Other Financing Activities
-76.571,3321,260735.9853.62,487
Financing Cash Flow
-15,41732,12333,830-4,15578,9284,697

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
842.28163.7319.611.32-9.19-
Miscellaneous Cash Flow Adjustments
639.18639.18---0
Net Cash Flow
-14,16312,6013,3378,357-10,790-4,884

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3,875-3,245-13,282-36,636-43,607655.69
Free Cash Flow Growth
------85.11%
Free Cash Flow Margin
-3.33%-3.80%-18.44%-55.57%-82.95%1.44%
Free Cash Flow Per Share
-154.91-136.49-585.50-1481.90-1922.2929.41
Levered Free Cash Flow
-45,57792,373627.58-24,219-49,766-8,801
Unlevered Free Cash Flow
-41,39596,0392,641-20,361-47,843-8,513

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,6241,859497.63530.96158.6923.01
Cash Income Tax Paid
1,192-282.5814,8701,2211,247-514.3
Change in Working Capital
-3,324-1,628-2,613-26,466-21,401-7,190